Page last updated: 2024-09-04

carbapenems and Allergic Bronchopulmonary Mycosis

carbapenems has been researched along with Allergic Bronchopulmonary Mycosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chai, LYA; Chee, YL; Chng, WJ; Hsu, LY; Jin, J; Khoo, AL; Koh, LP; Lim, BP; Lim, SE; Poon, LM; Teng, M; Ying, D; Zhao, YJ	1

Other Studies

1 other study(ies) available for carbapenems and Allergic Bronchopulmonary Mycosis

Article	Year
Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia. International journal of antimicrobial agents, 2018, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Humans; Invasive Pulmonary Aspergillosis; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2018

Article

Year

Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.

International journal of antimicrobial agents, 2018, Volume: 52, Issue:3

Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Humans; Invasive Pulmonary Aspergillosis; Piperacillin, Tazobactam Drug Combination; Prospective Studies

2018